Related Experiment Video
Updated: Aug 7, 2026
08:54
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
CAY-1, a novel antifungal compound from cayenne pepper
S Renault1, A J De Lucca, S Boue
1MycoLogics, Inc., Aurora, Colorado 80010, USA.
Medical Mycology
|March 12, 2003
Summary
Cayenne pepper saponin CAY-1 shows potent antifungal activity against various fungi, including Cryptococcus neoformans. This novel compound demonstrates low mammalian cell toxicity and disrupts fungal cell membranes, offering a promising therapeutic avenue.
Area of Science:
- Mycology
- Pharmacology
- Natural Products Chemistry
Background:
- Fungal infections pose significant health risks, necessitating the development of new antifungal agents.
- Capsicum frutescens (cayenne pepper) is a source of bioactive compounds with potential medicinal properties.
Purpose of the Study:
- To investigate the in vitro antifungal activity of CAY-1, a novel saponin from cayenne pepper.
- To elucidate the mechanism of action and assess the mammalian cell cytotoxicity of CAY-1.
Main Methods:
- In vitro antifungal assays were performed against 16 fungal strains, including Candida spp., Aspergillus fumigatus, and Cryptococcus neoformans.
- Minimum inhibitory concentrations (MICs) were determined.
- Synergistic effects with amphotericin B were evaluated.
- Mammalian cell line cytotoxicity assays were conducted.
Main Results:
- CAY-1 exhibited broad-spectrum antifungal activity, with MICs ranging from 4 to 16 microg/ml against Candida spp. and Aspergillus fumigatus.
- CAY-1 showed high efficacy against Cryptococcus neoformans, with 90% inhibition at 1 microg/ml.
- Synergistic antifungal activity was observed between CAY-1 and amphotericin B against Candida albicans and Aspergillus fumigatus.
- No significant cytotoxicity was observed in 55 mammalian cell lines at concentrations up to 100 microg/ml.
Conclusions:
- CAY-1 is a potent antifungal agent with a broad spectrum of activity and low mammalian cell toxicity.
- The mechanism of action involves the disruption of fungal cell membrane integrity.
- CAY-1 represents a promising candidate for the development of novel antifungal therapies.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...